Next Article in Journal
BRCA 1/2 Germline Mutation Predicts the Treatment Response of FOLFIRINOX with Pancreatic Ductal Adenocarcinoma in Korean Patients
Next Article in Special Issue
The Next Paradigm Shift in the Management of Clear Cell Renal Cancer: Radiogenomics—Definition, Current Advances, and Future Directions
Previous Article in Journal
The Functional Role of Extracellular Matrix Proteins in Cancer
Previous Article in Special Issue
Molecular Mechanisms of Resistance to Immunotherapy and Antiangiogenic Treatments in Clear Cell Renal Cell Carcinoma
 
 
Review

Article Versions Notes

Cancers 2022, 14(1), 239; https://doi.org/10.3390/cancers14010239
Action Date Notes Link
article xml file uploaded 4 January 2022 10:08 CET Original file -
article xml uploaded. 4 January 2022 10:08 CET Update -
article pdf uploaded. 4 January 2022 10:08 CET Version of Record -
article html file updated 4 January 2022 10:09 CET Original file -
article xml file uploaded 4 January 2022 10:25 CET Update -
article xml uploaded. 4 January 2022 10:25 CET Update https://www.mdpi.com/2072-6694/14/1/239/xml
article pdf uploaded. 4 January 2022 10:25 CET Updated version of record https://www.mdpi.com/2072-6694/14/1/239/pdf
article html file updated 4 January 2022 10:26 CET Update -
article html file updated 31 July 2022 01:56 CEST Update https://www.mdpi.com/2072-6694/14/1/239/html
Back to TopTop